CEDRUS’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $448K | Sell |
1,103
-217
| -16% | -$88.2K | 0.17% | 101 |
|
2024
Q2 | $424K | Sell |
1,320
-72
| -5% | -$23.1K | 0.21% | 88 |
|
2024
Q1 | $464K | Sell |
1,392
-33
| -2% | -$11K | 0.25% | 74 |
|
2023
Q4 | $386K | Buy |
1,425
+1
| +0.1% | +$271 | 0.24% | 89 |
|
2023
Q3 | $350K | Sell |
1,424
-17
| -1% | -$4.18K | 0.25% | 87 |
|
2023
Q2 | $437K | Sell |
1,441
-74
| -5% | -$22.5K | 0.31% | 61 |
|
2023
Q1 | $399K | Buy |
1,515
+24
| +2% | +$6.33K | 0.28% | 76 |
|
2022
Q4 | $358K | Buy |
1,491
+4
| +0.3% | +$960 | 0.29% | 82 |
|
2022
Q3 | $273K | Sell |
1,487
-2
| -0.1% | -$368 | 0.26% | 83 |
|
2022
Q2 | $250K | Buy |
1,489
+86
| +6% | +$14.5K | 0.24% | 91 |
|
2022
Q1 | $352K | Buy |
1,403
+196
| +16% | +$49.1K | 0.32% | 77 |
|
2021
Q4 | $310K | Buy |
+1,207
| New | +$310K | 0.3% | 96 |
|